Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/4/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Jag H. Khalsa

Wrong Dr. Jag H. Khalsa?

Chief, Medical Consequences Branc...

Local Address:  Rockville , Maryland , United States
National Institute on Drug Abuse, NIH
 
Background

Employment History

Board Memberships and Affiliations

  • Numerous Federal and NIH Level Committees
    HHS Viral Hepatitis Implementation Group

Education

  • Master's degree , herbal pharmacology
  • Ph.D.
    National Institute
  • Ph.D. , neuro-psycho-pharmacology
    SK&F
35 Total References
Web References
Editorial Board Members | USG
blumsrewarddeficiencysyndrome.com [cached]
Dr. Jag Khalsa, with about 50 years of experience in drug research, serves as the Chief of the Medical Consequences Branch, National Institute on Drug Abuse, NIH, DHHS; is responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 yrs as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) potential of chemicals [INDs/NDAs] and food additives) and clinical evaluator at FDA. He has published in pharmacology, toxicology, epidemiology and medical journals. He serves on editorial boards of Journals of Addiction Medicine, Research on HIV/AIDS and Palliative Care, Frontiers of Neuroscience, and Clinical Infectious Diseases. He also serves on numerous Federal and NIH level committees including the HHS Viral Hepatitis Implementation Group (VHIG), National Commission on Digestive Diseases and its two sub-committees (Liver Research, Diabetes Research), Federal Task Force on TB, NIH Steering Committee on Centers for AIDS Research, and Human Microbiome Workgroup. He has received distinguished service awards from the FDA Commissioner, NIDA and NIH Directors, Society of Neuro-Immune-Pharmacology (SNIP), Life Time Achievement Awards from SNIP and International Conference on Molecular Medicine (India) and MIT, India; a commendation from the US Congress, Awards of Merit from the International Society of Addiction Medicine (ISAM), the President of the American Society of Addiction Medicine (ASAM), and a Certificate of Appreciation from the Office of Assistant Secretary for Health (Drs. Howard Koh and Ron Valdiserri), DHHS. He has a PhD in neuro-psycho-pharmacology, a Master's degree in herbal pharmacology, post-doctoral training in CNS/Cardiovascular pharmacology at SK&F, and Toxicology at SRI International. Jag Khalsa, MS, PhD
Now, NIDA-supported researchers at McLean ...
www.fairkids.com [cached]
Now, NIDA-supported researchers at McLean Hospital in Belmont, Massachusetts, and Columbia University in New York City have shown that individuals who regularly smoke marijuana experience withdrawal symptoms after they stop smoking the drug."These studies suggest that in real-world situations abstinence from daily marijuana smoking creates withdrawal symptoms similar to those of other drugs of abuse," says Dr. Jag Khalsa of NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse.
6 Ways to Boost Your Mental Acuity At Work | Ririan Project
ririanproject.com [cached]
"We know a lot about the acute effects of marijuana use, but researchers are just now beginning to look at the long-term effects," says Dr. Jag Khalsa of NIDA's Center on AIDS and Other Medical Consequences of Drug Abuse.
Dr. Jag H. Khalsa National ...
www.brightice.org [cached]
Dr. Jag H. Khalsa National Institute of Health, USA
...
Dr. Jag Khalsa, with 47+ years of experience in drug research, serves as the Chief of the Medical Consequences Branch, NIDA/NIH/DHHS, is responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 yrs as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) potential of chemicals [INDs/NDAs] and food additives) and clinical evaluator at FDA. He has published in pharmacology, toxicology, epidemiology and medical journals. He serves on editorial boards of Journals of Addiction Medicine, Research on HIV/AIDS and Palliative Care, Frontiers of Neuroscience, and Clinical Infectious Diseases. He has received distinguished service awards from the FDA Commissioner, NIDA and NIH Directors, Society of Neuro-Immune-Pharmacology (SNIP), Life Time Achievement Awards from International Conference on Molecular Medicine (India) and MIT, India; a commendation from the US Congress, Awards of Merit from the International Society of Addiction Medicine (ISAM), and the President of the American Society of Addiction Medicine (ASAM). He has a Ph.D. in neuro-psycho-pharmacology, post-doctoral trainings in CNS/Cardiovascular pharmacology at SK&F, and Toxicology at SRI International. BIOGRAPHY
Dr. Jag H. Khalsa National ...
brightice.org [cached]
Dr. Jag H. Khalsa National Institute of Health, USA
...
Dr. Jag Khalsa, with 47+ years of experience in drug research, serves as the Chief of the Medical Consequences Branch, NIDA/NIH/DHHS, is responsible for developing/administering a national and international program of clinical research on medical and health consequences of drug abuse and co-occurring infections (HIV, HCV, and others). Prior to joining NIDA in 1987, he served for ~10 yrs as a pharmacologist/toxicologist assessing safety (carcinogenic/teratogenic) potential of chemicals [INDs/NDAs] and food additives) and clinical evaluator at FDA. He has published in pharmacology, toxicology, epidemiology and medical journals. He serves on editorial boards of Journals of Addiction Medicine, Research on HIV/AIDS and Palliative Care, Frontiers of Neuroscience, and Clinical Infectious Diseases. He has received distinguished service awards from the FDA Commissioner, NIDA and NIH Directors, Society of Neuro-Immune-Pharmacology (SNIP), Life Time Achievement Awards from International Conference on Molecular Medicine (India) and MIT, India; a commendation from the US Congress, Awards of Merit from the International Society of Addiction Medicine (ISAM), and the President of the American Society of Addiction Medicine (ASAM). He has a Ph.D. in neuro-psycho-pharmacology, post-doctoral trainings in CNS/Cardiovascular pharmacology at SK&F, and Toxicology at SRI International. BIOGRAPHY
Other People with the name "Khalsa":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304